ArticleAdvances in therapy2020

Secukinumab Use in Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis in Real-World Setting in Europe: Baseline Data from SERENA Study.

Uta Kiltz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.